Euclidean Capital’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.4M | Hold |
|
|||||
|
2025
Q1 | $5.74M | Hold |
|
|||||
|
2024
Q4 | $7.43M | Hold |
|
|||||
|
2024
Q3 | $14.7M | Hold |
|
|||||
|
2024
Q2 | $9.05M | Hold |
|
|||||
|
2024
Q1 | $10.6M | Hold |
|
|||||
|
2023
Q4 | $10.2M | Hold |
|
|||||
|
2023
Q3 | $7.87M | Hold |
|
|||||
|
2023
Q2 | $11.1M | Buy |
|
|||||
|
2023
Q1 | $7.82M | Hold |
|
|||||
|
2022
Q4 | $8.05M | Hold |
|
|||||
|
2022
Q3 | $10.8M | Hold |
|
|||||
|
2022
Q2 | $17.2M | Hold |
|
|||||
|
2022
Q1 | $19.2M | Hold |
|
|||||
|
2021
Q4 | $28.8M | Hold |
|
|||||
|
2021
Q3 | $17.6M | Hold |
|
|||||
|
2021
Q2 | $13.5M | Hold |
|
|||||
|
2021
Q1 | $16.6M | Hold |
|
|||||
|
2020
Q4 | $25.6M | Buy |
|